Woodline Partners’s NeuroSense Therapeutics NRSN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-19,581
Closed -$35.6K 631
2024
Q1
$35.6K Buy
+19,581
New +$35.6K ﹤0.01% 525